|Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants|
E Shimizu, K Hashimoto, N Okamura, K Koike, N Komatsu, C Kumakiri, ...
Biological psychiatry 54 (1), 70-75, 2003
|Critical role of brain-derived neurotrophic factor in mood disorders|
K Hashimoto, E Shimizu, M Iyo
Brain research reviews 45 (2), 104-114, 2004
|Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia|
K Hashimoto, T Fukushima, E Shimizu, N Komatsu, H Watanabe, ...
Archives of general psychiatry 60 (6), 572-576, 2003
|Increased levels of glutamate in brains from patients with mood disorders|
K Hashimoto, A Sawa, M Iyo
Biological psychiatry 62 (11), 1310-1316, 2007
|Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia|
K Ozawa, K Hashimoto, T Kishimoto, E Shimizu, H Ishikura, M Iyo
Biological psychiatry 59 (6), 546-554, 2006
|Emerging role of glutamate in the pathophysiology of major depressive disorder|
Brain research reviews 61 (2), 105-123, 2009
|Brain‐derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions|
Psychiatry and clinical neurosciences 64 (4), 341-357, 2010
|Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits|
E Shimizu, K Hashimoto, M Iyo
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 126 …, 2004
|Interactions of selective serotonin reuptake inhibitors with subtypes of σ receptors in rat brain|
N Narita, K Hashimoto, S Tomitaka, Y Minabe
European journal of pharmacology 307 (1), 117-119, 1996
|Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients|
K Hashimoto, G Engberg, E Shimizu, C Nordin, LH Lindström, M Iyo
Progress in Neuro-Psychopharmacology and Biological Psychiatry 29 (5), 767-769, 2005
|Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders|
K Hashimoto, B Malchow, P Falkai, A Schmitt
European archives of psychiatry and clinical neuroscience 263 (5), 367-377, 2013
|Increased serum levels of glutamate in adult patients with autism|
A Shinohe, K Hashimoto, K Nakamura, M Tsujii, Y Iwata, KJ Tsuchiya, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 30 (8), 1472-1477, 2006
|R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects|
C Yang, Y Shirayama, JC Zhang, Q Ren, W Yao, M Ma, C Dong, ...
Translational psychiatry 5 (9), e632, 2015
|Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals|
K Hashimoto, K Ishiwata
Current pharmaceutical design 12 (30), 3857-3876, 2006
|Decreased levels of serum brain-derived neurotrophic factor in female patients with eating disorders|
M Nakazato, K Hashimoto, E Shimizu, C Kumakiri, H Koizumi, N Okamura, ...
Biological psychiatry 54 (4), 485-490, 2003
|Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder|
T Yoshida, M Ishikawa, T Niitsu, M Nakazato, H Watanabe, T Shiraishi, ...
PloS one 7 (8), e42676, 2012
|Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls|
E Shimizu, K Hashimoto, H Watanabe, N Komatsu, N Okamura, K Koike, ...
Neuroscience Letters 351 (2), 111-114, 2003
|Calcium decoding mechanisms in plants|
K Hashimoto, J Kudla
Biochimie 93 (12), 2054-2059, 2011
|D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats|
J Karasawa, K Hashimoto, S Chaki
Behavioural brain research 186 (1), 78-83, 2008
|Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol|
K Hashimoto, Y Fujita, E Shimizu, M Iyo
European journal of pharmacology 519 (1-2), 114-117, 2005